Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study

Int J Rheum Dis. 2019 Jun;22(6):1041-1045. doi: 10.1111/1756-185X.13554. Epub 2019 Apr 2.

Abstract

Aim: Low levels of vitamin D (25OHD) have been found to associated with digital ulcers (DUs) in systemic sclerosis (SSc), although only cross-sectional studies have been performed. We aimed to investigate if variations in vitamin D serum levels over time affect DU in SSc.

Methods: This is a retrospective study on 65 patients. 25OHD was measured in 2011 and 2016 and its variations correlated with DU.

Results: The mean age of our cohort was 58 (SD 12) years with a mean disease duration of 9.5 (5.3) years. Most of our patients had a limited SSc (69.2%). At baseline 50.8% and 41.5% after 5 years had 25OHD <30 ng/mL. Patients receiving supplementation (8750 IU/wk) at baseline numbered 39 (60.0%) and 45 (69.2%) at the end of follow up. Nevertheless, 31 (47.7%) had a decrease of 25OHD in 5 years. In univariate analysis, patients with incident DU had a decrease in 25OHD as compared to patients with no incident DU (-17.4 [37.0] vs 13.0 [89.5], P = 0.018). No differences in 25OHD variations were found for other disease characteristics. In multivariate analysis correcting for previous DU and modified Rodnan Skin Score at baseline, patients with a decrease in 25OHD had an increased risk of developing DU (odds ratio 16.6; 95% CI 1.7-164.5, P = 0.017).

Conclusions: A decrease in 25OHD is associated with the risk of developing DUs. In addition, vitamin D supplementation with the doses currently recommended may be insufficient in SSc. Further studies in wider cohorts are needed to confirm these results.

Keywords: digital ulcers; supplementation; systemic sclerosis; vitamin D.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Dietary Supplements
  • Female
  • Humans
  • Incidence
  • Italy / epidemiology
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Scleroderma, Systemic / blood*
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy
  • Scleroderma, Systemic / epidemiology
  • Skin Ulcer / blood*
  • Skin Ulcer / diagnosis
  • Skin Ulcer / epidemiology
  • Skin Ulcer / prevention & control
  • Time Factors
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood
  • Vitamin D Deficiency / blood*
  • Vitamin D Deficiency / diagnosis
  • Vitamin D Deficiency / drug therapy
  • Vitamin D Deficiency / epidemiology

Substances

  • Biomarkers
  • Vitamin D
  • 25-hydroxyvitamin D